Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2007

CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?

  • Andrew J. Hutt,
From the journal Drug Metabolism and Drug Interactions
https://doi.org/10.1515/DMDI.2007.22.2-3.79
Published Online: 2007-06

©2011 by Walter de Gruyter GmbH & Co.

From the journal
Drug Metabolism and Drug Interactions
Drug Metabolism and Drug Interactions
Volume 22 Issue 2-3
Submit manuscript

Journal and Issue

Articles in the same Issue

CONTENTS
CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
A REVIEW ON THE RELATION BETWEEN THE BRAIN-SERUM CONCENTRATION RATIO OF DRUGS AND THE INFLUENCE OF P-GLYCOPROTEIN
EVALUATION OF THE CHEMOPROTECTIVE EFFECT OF Biophytum sensitivum (L.) DC EXTRACT AGAINST CYCLOPHOSPHAMIDE INDUCED TOXICITY IN SWISS ALBINO MICE
EFFECT OF RIFAMPICIN PRETREATMENT ON THE TRANSPORT ACROSS RAT INTESTINE AND ORAL PHARMACOKINETICS OF ORNIDAZOLE IN HEALTHY HUMAN VOLUNTEERS
BIOAVAILABILITY OF DICLOFENAC SODIUM AFTER PRETREATMENT WITH DIOSMIN IN HEALTHY VOLUNTEERS
EFFECT OF SILYMARIN ON THE ORAL BIOAVAILABILITY OF RANITIDINE IN HEALTHY HUMAN VOLUNTEERS
ISOFLURANE REDUCES THE SYNTHESIS OF SURFACTANT-RELATED PROTEIN A OF ALVEOLAR TYPE II CELLS INJURED BY H2O2
RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY
Downloaded on 1.6.2024 from https://www.degruyter.com/document/doi/10.1515/DMDI.2007.22.2-3.79/html
Scroll to top button